甲型H1N1流感pdm09重症患者入住ICU:SEMICYUC推荐意见的影响
本研究为前瞻性多中心观察性研究,基于GETGAG/SEMICYUC登记处,纳入2205例重症甲型H1N1流感ICU患者,按流行期分为2009-2011年组(1337例,60.6%)和2013-2015年组(868例,39.4%)。第二期患者年龄和入ICU时病情严重度显著更高,合并感染更多。与第一期相比,第二期诊断更早(70.8% vs 61.1%,P<.001),激素使用更少(39.7% vs 44.9%,P<.05),无创通气使用更多(47.4% vs 33.2%,P<.001),疫苗接种率更高(11.1% vs 1.7%,P<.001),院内感染更少(9.8% vs 16%,P<.001),但病死率无变化(24.2% vs 20.7%)。结论认为SEMICYUC(2012)推荐意见使诊断更早、激素使用改善,但治疗延迟、疫苗接种率和无创通气使用仍是待解决的挑战。
要点
- 第二期(2013-2015)诊断更早:70.8% vs 第一期(2009-2011)61.1%,P<.001,但治疗启动时间无变化。
- 第二期激素使用更少:39.7% vs 44.9%,P<.05;无创通气使用更多:47.4% vs 33.2%,P<.001。
- 第二期疫苗接种率更高:11.1% vs 1.7%,P<.001;院内感染更少:9.8% vs 16%,P<.001。
- 两期病死率无变化:24.2% vs 20.7%;第二期患者年龄和入ICU时病情严重度显著更高,合并感染更多。
- 第二期需要机械通气更少但通气天数更多,血管活性药物使用更多,俯卧位通气更多。
适用人群与场景
- 感染重症甲型H1N1流感并入住ICU的患者,来自GETGAG/SEMICYUC登记处。
研究设计与关键结果
- 前瞻性多中心观察性研究,纳入2205例重症甲型H1N1流感ICU患者,按流行期分为2009-2011年组(1337例,60.6%)和2013-2015年组(868例,39.4%)。
- 第二期较第一期诊断更早:70.8% vs 61.1%,P<.001;治疗启动时间无变化。
- 第二期激素使用更少:39.7% vs 44.9%,P<.05;无创通气使用更多:47.4% vs 33.2%,P<.001;疫苗接种率更高:11.1% vs 1.7%,P<.001。
- 第二期院内感染更少:9.8% vs 16%,P<.001;病死率无变化:24.2% vs 20.7%。
- 第二期患者年龄和入ICU时病情严重度显著更高,合并感染更多;需要机械通气更少但通气天数更多,血管活性药物使用更多,俯卧位通气更多。
证据类型、等级与局限
- 证据类型:前瞻性多中心观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- SEMICYUC(2012)推荐意见实施后,重症甲型H1N1流感患者诊断更早、激素使用更少、无创通气使用更多、疫苗接种率更高、院内感染更少,但病死率无变化。
- 作者认为待解决的挑战包括治疗延迟、疫苗接种率和无创通气使用。
指南或共识出处
- SEMICYUC(2012)推荐意见。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the impact of the recommendations of the SEMICYUC (2012) on severe influenza A.
DESIGN: A prospective multicenter observational study was carried out.
PATIENTS: Patients infected with severe influenza A (H1N1) from the GETGAG/SEMICYUC registry.
INTERVENTIONS: Analysis of 2 groups according to the epidemic period of the diagnosis (2009-2011; 2013-2015).
VARIABLES: Demographic, temporal, comorbidities, severity, treatments, mortality, late diagnosis and place of acquisition.
RESULTS: A total of 2,205 patients were included, 1,337 (60.6%) in the first period and 868 (39.4%) in the second one. Age and severity on admission were significantly greater in the second period, as well as co-infection. With regard to the impact of the recommendations, in the second period the diagnosis was established earlier (70.8 vs. 61.1%, P<.001), without changes in the start of treatment. Patients received less corticosteroid treatment (39.7 vs. 44.9%, P<.05), more NIMV was used (47.4 vs. 33.2%, P<.001) and more vaccination was made (11.1 vs. 1.7%, P<.001), without changes in mortality (24.2 vs. 20.7%). A decrease in nosocomial infection was also noted (9.8 vs. 16%, P<.001). Patients needed less MV with more days of ventilation, more vasopressor drug use and more ventral decubitus.
CONCLUSIONS: The management of patients with severe influenza A (H1N1) has changed over the years, though without changes in mortality. The recommendations of the SEMICYUC (2012) have allowed earlier diagnosis and improved corticosteroid use. Pending challenges are the delay in treatment, the vaccination rate and the use of NIMV.
参考来源
- Marin-Corral J, Climent C, Muñoz R, et al. Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC. Med Intensiva (Engl Ed). 2018. PMID: 29559173. doi:10.1016/j.medin.2018.02.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。